Vasomedical Timeline
Since 1995 provided innovative, reliable, and accessible diagnostic and therapeutic solutions. Our mission is to help physicians detect, understand, and manage heart and vascular diseases earlier and more effectively — so patients can live longer, healthier, and fuller lives.
1995 – EECP Foundation
-
Commercialization of EECP® therapy systems
-
Core business focused on non-invasive cardiovascular therapy
-
U.S. and international sales & servicing
2010 – Portfolio Expansion
-
Introduction of BIOX products
-
Entry into ambulatory ECG & BP monitoring
-
Establishment of China-based manufacturing & R&D
2011 – Biox Full Ownership
-
Completion of 100% ownership of Biox Instruments
-
Consolidation of device IP and production control
-
Strengthened global regulatory footprint
2021–Present – SaaS Transformation
-
Expansion of ARCS® Cloud platform
-
Subscription-based ECG/BP analysis & reporting
-
Portfolio centered on:
-
Biox™ ambulatory monitors
-
ARCS® Cloud platform
-